Notable Labs, Ltd. NTBLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow NTBLQ
Growth Flags
show if company had growth for consecutive years
| Jun '24 | Mar '24 | Dec '23 | Sep '23 | Older periods | |
|---|---|---|---|---|---|
| (79.79%) | (55.71%) | 103.08% | 17.65% |
+8 more TTM periods Free account |
|
| (59.14%) | (40.07%) | (89.92%) | 13.64% | ||
ROIC |
(295.36%) | (229.58%) | (263.36%) | 0.00% | |
Return on Tangible Assets |
(219.03%) | (92.37%) | (86.33%) | 21.00% | |
Average Days of Receivables |
0.00 | 0.00 | — | — | |
Free Cash Flow per Share |
(1.61) | (1.60) | (4.17) | 6.21 | |
Free Cash Flow |
(15.20) | (14.42) | (13.78) | 13.91 | |
Capital Expenditures |
(0.05) | (0.07) | (0.06) | 8.32 | |
Piotroski F-Score |
2.00 | 3.00 | 2.00 | — | |
| Other line items | |||||
Cash ROIC |
(131.75%) | (71.92%) | (50.42%) | 14.30% | |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.16 | 0.00 | |
Inventory Turnover |
— | — | 0.00 | — | |
Average Days of Payables |
0.00 | 0.00 | 3,093.89 | 0.00 | |
Days of Inventory on Hand |
— | — | 0.00 | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
(3,590.36%) | (4,480.77%) | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
(5,738.55%) | (8,105.77%) | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
(796.39%) | (581.73%) | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.44 | 1.64 | 1.22 | 1.45 | |
Depreciation/Fixed assets |
1.29 | 1.61 | (1.11) | — | |
Capex/Depreciation |
(0.11) | (0.15) | 0.19 | 0.00 | |
Revenue per Share |
(0.02) | (0.01) | 0.00 | 0.00 | |
Operating CF per Share |
(1.60) | (1.59) | (4.15) | 2.50 | |
Capex per Share |
(0.01) | (0.01) | (0.02) | 3.72 | |
Capex to Sales |
(0.30) | (0.64) | 0.00 | 0.00 | |
Net Profit Margin |
6,350.60% | 8,421.15% | 0.00% | 0.00% |
Columns are period end dates